Dipanjan Ghosh

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Respiratory Syndrome Coronavirus

Anti Inflammatory

Top Venues

Molecules (Basel, Switzerland)

Nanoscale advances

Molecular biotechnology

In silico pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Prashant Dubey, Ankaj Kumar, Klaudi K Vaiphei, Sargun Basrani, Ashwini Jadhav, Carl-Eric Wilen, Jessica M Rosenholm, Kuldeep Kumar Bansal, Rudra Chakravarti, Dipanjan Ghosh, Arvind Gulbake
A poly-δ-decalactone (PDL) based nanoemulgel for topical delivery of ketoconazole and eugenol against Candida albicans . Nanoscale advances (2024)
Arijit Ghosh, Paritosh K Kar, Anupam Gautam, Rahul Gupta, Rajveer Singh, Rudra Chakravarti, Velayutham Ravichandiran, Shubhra Ghosh Dastidar, Dipanjan Ghosh, Syamal Roy
An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives. RSC medicinal chemistry 13 (6) (2022)
Anam Najib Khan, Rajveer Singh, Arka Bhattacharya, Sonu Kumar, Arijit Ghosh, Debasish Nag, Velayutham Ravichandiran, Dipanjan Ghosh
Glucogallin Attenuates RAW 264.7 Cells from Arsenic Trioxide Induced Toxicity via the NF-ҡB/NLRP3 Pathway. Molecules (Basel, Switzerland) 27 (16) (2022)
Rajveer Singh, Shivani Chandel, Arijit Ghosh, Tushar Matta, Anupam Gautam, Arka Bhattacharya, Srivalliputturu Sarath Babu, Soumi Sukla, Debasish Nag, Velayutham Ravichandiran, Syamal Roy, Dipanjan Ghosh
Glucogallin Attenuates the LPS-Induced Signaling in Macrophages and Protects Mice against Sepsis. International journal of molecular sciences 23 (19) (2022)
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, Syamal Roy, Dipanjan Ghosh
A review on potential of natural products in the management of COVID-19. RSC advances 11 (27) (2021)
Rahul Gupta, Tawsif Ahmed Kazi, Dhritiman Dey, Arijit Ghosh, V Ravichandiran, Snehasikta Swarnakar, Syamal Roy, Swadesh Ranjan Biswas, Dipanjan Ghosh
CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout. Applied microbiology and biotechnology 105 (20) (2021)
Rajveer Singh, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Rudra Chakravarti, Syamal Roy, V Ravichandiran, Dipanjan Ghosh
Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules. Molecular biotechnology 63 (6) (2021)
Rajveer Singh, Anupam Gautam, Shivani Chandel, Vipul Sharma, Arijit Ghosh, Dhritiman Dey, Syamal Roy, V Ravichandiran, Dipanjan Ghosh
Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach. In silico pharmacology 9 (1) (2021)
Rajveer Singh, Anupam Gautam, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Syamal Roy, Velayutham Ravichandiran, Dipanjan Ghosh
Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study. Molecules (Basel, Switzerland) 25 (20) (2020)